Moran Wealth Management LLC Has $16.50 Million Stock Position in DaVita Inc. (NYSE:DVA)

Moran Wealth Management LLC raised its position in DaVita Inc. (NYSE:DVA) by 102.2% in the fourth quarter, according to its most recent disclosure with the SEC. The firm owned 110,322 shares of the company’s stock after acquiring an additional 55,756 shares during the period. Moran Wealth Management LLC owned approximately 0.13% of DaVita worth $16,499,000 as of its most recent filing with the SEC.

Several other hedge funds and other institutional investors have also recently modified their holdings of the company. Franklin Resources Inc. lifted its holdings in shares of DaVita by 134.6% in the 3rd quarter. Franklin Resources Inc. now owns 54,901 shares of the company’s stock worth $8,885,000 after purchasing an additional 31,502 shares in the last quarter. FMR LLC lifted its stake in shares of DaVita by 659.9% in the third quarter. FMR LLC now owns 177,406 shares of the company’s stock valued at $29,082,000 after buying an additional 154,061 shares in the last quarter. Atom Investors LP bought a new position in shares of DaVita in the third quarter valued at $4,094,000. Assenagon Asset Management S.A. increased its position in shares of DaVita by 201.7% during the fourth quarter. Assenagon Asset Management S.A. now owns 74,617 shares of the company’s stock worth $11,159,000 after acquiring an additional 49,885 shares in the last quarter. Finally, Neo Ivy Capital Management bought a new stake in shares of DaVita during the third quarter worth about $726,000. Institutional investors own 90.12% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research firms have issued reports on DVA. Sanford C. Bernstein set a $184.00 price target on DaVita in a research note on Friday, February 21st. Barclays lifted their target price on DaVita from $164.00 to $169.00 and gave the company an “equal weight” rating in a research report on Tuesday, February 18th. Finally, Cowen restated a “hold” rating on shares of DaVita in a research note on Tuesday, February 18th. One research analyst has rated the stock with a sell rating, four have assigned a hold rating and two have given a buy rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus price target of $166.33.

DaVita Stock Performance

Shares of DaVita stock opened at $146.73 on Monday. The business’s fifty day simple moving average is $159.43 and its 200 day simple moving average is $157.95. The company has a current ratio of 1.26, a quick ratio of 1.21 and a debt-to-equity ratio of 23.18. DaVita Inc. has a 12 month low of $125.64 and a 12 month high of $179.60. The firm has a market capitalization of $11.74 billion, a P/E ratio of 13.66, a price-to-earnings-growth ratio of 1.07 and a beta of 0.99.

DaVita (NYSE:DVA) last released its earnings results on Thursday, February 13th. The company reported $2.24 EPS for the quarter, topping analysts’ consensus estimates of $2.14 by $0.10. DaVita had a return on equity of 115.48% and a net margin of 7.31%. As a group, analysts anticipate that DaVita Inc. will post 10.76 EPS for the current year.

About DaVita

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.